Linda Röhner

The IKZF1–IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated Macrophages

Dimitrios Mougiakakos, Christian Bach, Martin Böttcher et al. · Cancer Immunology Research · 2021 · 51 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1)

Tatjana Meyer, Nikolaus Jahn, Stefanie Lindner et al. · Leukemia · 2019 · 28 citations · Full text

Life Sciences, Genetics, Oncology +16

MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia development

Edith Schneider, Anna Staffas, Linda Röhner et al. · Experimental Hematology · 2016 · 20 citations

Life Sciences, Molecular Biology, Oncology +14

Comprehensive CRISPR-Cas9 screens identify genetic determinants of drug responsiveness in multiple myeloma

Stephan Bohl, Laura K. Schmalbrock, Imke Bauhuf et al. · Blood Advances · 2021 · 20 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia

Edith Schneider, Anna Staffas, Linda Röhner et al. · Haematologica · 2017 · 12 citations · Full text

Medicine, Molecular Biology, Oncology +15